CAPTRUST FINANCIAL ADVISORS - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 7 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q2 2022$3,000
+200.0%
57,659
+182.6%
0.00%
Q1 2022$1,000
-50.0%
20,402
-52.2%
0.00%
Q4 2021$2,000
+100.0%
42,659
+90.0%
0.00%
Q3 2021$1,000
-50.0%
22,4570.0%0.00%
Q2 2021$2,0000.0%22,4570.0%0.00%
Q1 2021$2,000
+100.0%
22,4570.0%0.00%
Q4 2020$1,0000.0%22,457
+3.7%
0.00%
Q2 2020$1,00021,6570.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders